Table 1.

Clinical features of Parkinson's disease patients.

								MDS-UPDRS Part III
Patient	Age	Gender	Disease duration (year)	Hoehn & Yahr	L-Dopa dosage (mg/day)	MMSE	MoCAJ	PD without L-DOPA	PD with L-DOPA
1	76	F	1	2	0	29	27	15	15
2	65	F	1	2	200	29	24	10	3
3	65	F	1	2	200	28	28	13	5
4	72	F	1	2	200	29	24	31	20
5	63	M	1	2	300	29	26	15	9
6	72	F	1	2	400	26	24	27	23
7	45	M	2	2	200	30	25	19	17
8	73	F	2	2	300	30	23	26	22
9	70	M	2	2	400	23	26	46	26
10	75	F	2	2	400	27	25	37	20
11	83	F	4	1	200	29	21	31	22
12	67	M	4	2	250	25	25	34	19
13	83	F	5	2	200	29	26	26	16
14	66	M	5	1	300	29	26	31	17
15	72	M	5	2	500	27	26	42	31
16	74	M	7	2	400	27	22	46	35
Mean ± SEM	70.06 ± 2.22		2.75 ± 0.49	1.87 ± 0.09	278.13 ± 30.61	27.88 ± 0.48	24.88 ± 0.46	28.06 ± 2.86	18.75 ± 2.11

F, female; M, male; MMSE, Mini-Mental State Examination; MoCAJ, Japanese version of Montreal Cognitive Assessment.